New Generation of Glucose Control Technologies Incorporating AI/ML Tools/Strategies (R01 - Clinical Trial Optional)
Grant Opportunity Analysis
The National Institute of Diabetes and Digestive and Kidney Diseases, part of NIH within HHS, is funding research to advance a new generation of glucose control technologies that use AI/ML tools and strategies to improve diabetes management. The work focuses on overcoming barriers to more effective open- and closed-loop systems through improved sensing, hormone delivery, AI/ML-driven algorithms, and digital twin modeling. The opportunity is tied to the Special Diabetes Program and supports research for people with type 1 diabetes, with clinical trials optional and awards limited to up to $500,000 in direct costs per year for as long as five years. Applications are due June 17, 2026, and the grant point of contact is NIDDK_DEM@nih.gov.
Eligible Applicants
Refer to Section III. Eligibility Information in the NOFO for additional information on eligibility.Foreign Organizations/International Collaborations:Non-domestic (non-U.S.) Entities (Foreign Organizations) are eligible to apply.Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply.Foreign components, as defined in the NIH Grants Policy Statement, are allowed.